The Board of Krishna Institute of Medical Sciences at its meeting held on 28 November 2023 has approved the appointment of Adwik Bollineni (DIN: 06549059) as an Additional Director (Non-Executive Non-Independent) of the Company with effect from 28 November 2023. Powered by Capital Market - Live News

Net profit of Krishna Institute of Medical Sciences declined 5.24% to Rs 92.02 crore in the quarter ended September 2023 as against Rs 97.11 crore during the previous quarter ended September 2022. Sales rose 15.67% to Rs 652.48 crore in the quarter ended September 2023 as against Rs 564.07 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales652.48564.07 16 OPM %27.1727.03 - PBDT171.22153.76 11 PBT138.62122.64 13 NP92.0297.11 -5 Powered by Capital Market - Live News

Krishna Institute of Medical Sci. will hold a meeting of the Board of Directors of the Company on 7 November 2023.Powered by Capital Market - Live News

Krishna Institute of Medical Sciences has acquired an additional equity stake of 5.72% in SPANV Medisearch Lifesciences, subsidiary company. Consequently, the Company now holds 56.72% of the total paid-up equity share capital of SPANV Medisearch Lifesciences. Powered by Capital Market - Live News

Krishna Institute of Medical Sciences announced that its material subsidiary, KIMS Hospital Enterprises has acquired 8.06% in M/s. Kondapur Healthcare at a cost of Rs 10 crore. Kondapur Healthcare is a green field project which is presently under construction of a hospital. Powered by Capital Market - Live News